Gourt > Health > Pharmacy > Drugs and Medications > A > Atazanavir
Atazanavir, trade name Reyataz®, (formerly known as BMS-232632) is an antiretroviral drug of the protease inhibitor (PI) class. Like other antiretrovirals, it is used to treat infection of human immunodeficiency virus (HIV).
Atazanavir is distinguished from other PIs in that it can be given once-daily (rather than requiring multiple doses per day) and has lesser effects on the patient's lipid profile (the amounts of cholesterol and other fatty substances in the blood). Like other protease inhibitors, it is used only in combination with other HIV medications.
The Food and Drug Administration (FDA) approved atazanavir on June 20, 2003. Atazanavir is the first PI approved for once-daily dosing, and also appears to be less likely to cause lipodystrophy and elevated cholesterol as side effects. It may also not be cross-resistant with other PIs. When boosted with ritonavir it is of equivalent potency to lopinavir for use in salvage therapy in patients with a degree of drug resistance.
More on [ Atazanavir ]
Rx North FDA Approves Labeling Update for Reyataz (atazanavir sulfate) Capsules to Include 96-Week Data.. http://bit.ly/48tojE
rxnorth (Pharmacy) Sat, 07 Nov 2009 02:39:43 -0000
Rx North FDA Approves Labeling Update for Reyataz (atazanavir sulfate) Capsules to Include 96-Week Data.. http://bit.ly/48tojE
Canada Drugs FDA Approves Labeling Update for Reyataz (atazanavir sulfate) Capsules to Include 96-W.. http://bit.ly/48tojE
CanadaDrugs (Pharmacy) Sat, 07 Nov 2009 02:24:04 -0000
Canada Drugs FDA Approves Labeling Update for Reyataz (atazanavir sulfate) Capsules to Include 96-W.. http://bit.ly/48tojE
The FINANCIAL -- FDA Approves Labeling Update for REYATAZ (atazanavir sulfate) Capsules to Incl.. http://bit.ly/1BYC0G
TheFINANCIAL (The FINANCIAL) Fri, 06 Nov 2009 12:58:20 -0000
The FINANCIAL -- FDA Approves Labeling Update for REYATAZ (atazanavir sulfate) Capsules to Incl.. http://bit.ly/1BYC0G
RT @shawncmason FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules t.. http://bit.ly/JuCWd Plz RT
finallyfeelgood (Shawn Mason) Fri, 06 Nov 2009 01:34:45 -0000
RT @shawncmason FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules t.. http://bit.ly/JuCWd Plz RT
FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to Include 96-Week Data for Previously .. http://bit.ly/gQkaO
BW_Health (BW Health News) Thu, 05 Nov 2009 23:37:00 -0000
FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to Include 96-Week Data for Previously .. http://bit.ly/gQkaO
Philadelphia: FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to Include 9.. http://bit.ly/2gJ93t
PhiladelphiaCP (Philadelphia CP) Thu, 05 Nov 2009 23:24:56 -0000
Philadelphia: FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to Include 9.. http://bit.ly/2gJ93t
MedlinePlus: Reyataz - Features information about dosage, usage, warnings, and side effects.
Meta Description: [ Atazanavir ]
Reyataz - Official pharmaceutical company website from Bristol-Myers Squibb.
Reyataz Consumer Information - FDA - Patient FAQ in html format with a link to approved labeling in pdf format.
Meta Description: [ Patient Information Sheet for Atazanavir Sulfate (marketed as Reyataz) ]
